Clinical Trial

JAK Signaling in Depression and Cognition in Male Football Players

Name: JAK Signaling in Depression and Cognition in Male Football Players — clinical trial record (NCT07608796)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: JAK DC in Play

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is being done to learn more about the role of inflammation in depressive and cognitive symptoms in patients with depression who have played at least 10 years of organized football. This will be evaluated using a medication called baricitinib that blocks one aspect of inflammation.

Trial Details

NCT Number	NCT07608796
Lead Sponsor	Emory University
Conditions	Depressive Symptoms, Cognitive Symptom
Enrollment	30 participants
Start Date	2026-06
Primary Completion	2027-10 (estimated)
Study Completion	2027-10 (estimated)
Updated on ClinicalTrials.gov	2026-05-27